No Apparent Harm From Omitting Lymph Node Dissection in Selected Breast Cancers

(MedPage Today) -- SAN ANTONIO -- Patients with early breast cancer who skipped axillary lymph node dissection (ALND) lived just as long as those who underwent sentinel lymph node biopsy (SLNB), the randomized INSEMA trial showed.
The estimated...